Effects of allergen inhalation and oral glucocorticoid on concentrations of serum-soluble CD86 in allergic asthmatics.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Immunology

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CLIM.2005.01.002PMID 15885641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine.

  2015cited by this paper
• Soluble CD86 protein in serum samples of patients with asthma

  2004cited by this paper
• Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients

  2002cited by this paper
• Codelivery of DNA coding for the soluble form of CD86 results in the down-regulation of the immune response to DNA vaccines.

  2001cited by this paper
• A native soluble form of CTLA-4.

  2000cited by this paper
• Soluble CD86 is a costimulatory molecule for human T lymphocytes.

  2000cited by this paper
• Costimulation of T cells.

  2000cited by this paper
• Molecular mechanisms of glucocorticoid action: what is important?

  2000cited by this paper
• Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation.

  1999cited by this paper
• Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice.

  1999cited by this paper
• Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma

  1999cited by this paper
• Development of murine allergic asthma is dependent upon B7-2 costimulation.

  1998cited by this paper
• CD28/B7 costimulation: a review.

  1998cited by this paper
• The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.

  1997cited by this paper
• Molecular mechanisms of steroid action in asthma.

  1996cited by this paper
• B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct.

  1996cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper
• The Complexities of T‐Cell Co‐stimulation: CD28 and Beyond

  1996cited by this paper
• Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

  1995cited by this paper
• Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids

  1995cited by this paper
• B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

  1995cited by this paper
• Early and late asthmatic reaction after allergen challenge.

  1994cited by this paper
• Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics.

  1993cited by this paper
• Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma.

  1992cited by this paper
• Effect of therapy on bronchial hyperresponsiveness in the long‐term management of asthma

  1988cited by this paper
• Late asthmatic responses.

  1987cited by this paper
• Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions.

  1985cited by this paper
• [Late asthmatic response].

  1985cited by this paper
• Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.

  1984cited by this paper

• Costimulation Immunotherapy in Allergies and Asthma

  2015cites this paper
• Costimulation Immunotherapy in Infectious Diseases

  2015cites this paper
• NSFC spurs significant basic research progress of respiratory medicine in China

  2015cites this paper
• Multiple In Vitro and In Vivo Regulatory Effects of Budesonide in CD4+ T Lymphocyte Subpopulations of Allergic Asthmatics

  2012cites this paper
• The Role of Costimulatory Molecules in Allergic Disease and Asthma

  2009cites this paper
• CD28/CTLA‐4–CD80/CD86 and ICOS–B7RP‐1 costimulatory pathway in bronchial asthma

  2006cites this paper
• Current world literature. Upper airway disease.

  2006cites this paper
• Increase in concentration of soluble CD86 after segmental allergen challenge in patients with allergic asthma.

  2006cites this paper
• CTLA‐4 gene polymorphisms and natural soluble CTLA‐4 protein in psoriasis vulgaris

  2006cites this paper
• Plasma concentrations of soluble CTLA‐4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children

  2006cites this paper